The research proposal requests funding to enable us to continue as the Statistical and Data Management Center for the National Surgical Adjuvant Breast and Bowel Project (NSABP). Our objectives include: 1. To provide data management support for the collection, editing, and entry of data from trials being conducted by the NSABP. 2. To work with the members and colleagues in the operations center to design, implement, manage, and analyze new and current clinical trials which address therapeutic questions. 3. To work with clinical colleagues in the design and analysis of trials which address questions regarding scientific issues adjunctive to the primary research efforts. 4. To contribute to the statistical literature by developing statistical methods relevant to the design and analysis of clinical trials. 5. To conduct a quality assurance program that encompasses the five major areas of; a) institutional performance monitoring (to include site visit audits), b) patient safety and treatment monitoring (to include medical review), c) cooperative group regulatory compliance (to include toxicity reporting), d) data quality monitoring (to include internal quality control), and e) continuing education. 6. To pilot a computerized system for: a) assisting in patient scheduling, b) standardizing systems across our main members and, ultimately c) beginning direct data entry and verification from our main members. 7. To prepare annual Progress Reports for the membership and study sponsors. 8. To utilize the existing database and collaborate with others who have similar interests in addressing relevant clinical trial issues such as cost-effectiveness of routine testing, prognostic factors for disease recurrence, etc. 9. To support the NSABP Operations Center in the conduct of their activities relative to institutional performance evaluations and reimbursement, maintenance of administrative computer files, and compliance to regulatory requirements.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
Application #
Study Section
Cancer Clinical Investigation Review Committee (CCI)
Program Officer
Mooney, Margaret M
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pittsburgh
Biostatistics & Other Math Sci
Schools of Public Health
United States
Zip Code
Saha, Poornima; Regan, Meredith M; Pagani, Olivia et al. (2017) Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials. J Clin Oncol 35:3113-3122
Balmert, Lauren; Jeong, Jong-Hyeon (2017) Nonparametric inference on quantile lost lifespan. Biometrics 73:252-259
Regan, M M; Walley, B A; Francis, P A et al. (2017) Concurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: an exploratory analysis of TEXT and SOFT. Ann Oncol 28:2225-2232
Ternès, Nils; Rotolo, Federico; Michiels, Stefan (2017) Robust estimation of the expected survival probabilities from high-dimensional Cox models with biomarker-by-treatment interactions in randomized clinical trials. BMC Med Res Methodol 17:83
Ribi, Karin; Bernhard, Jürg; Luo, Weixiu et al. (2016) Reply to F. Tomao et al. J Clin Oncol 34:4189-4190
Regan, Meredith M; Francis, Prudence A; Pagani, Olivia et al. (2016) Absolute Benefit of Adjuvant Endocrine Therapies for Premenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: TEXT and SOFT Trials. J Clin Oncol 34:2221-31
Phillips, Kelly-Anne; Regan, Meredith M; Ribi, Karin et al. (2016) Adjuvant ovarian function suppression and cognitive function in women with breast cancer. Br J Cancer 114:956-64
Christian, Nicholas J; Ha, Il Do; Jeong, Jong-Hyeon (2016) Hierarchical likelihood inference on clustered competing risks data. Stat Med 35:251-67
Ribi, Karin; Luo, Weixiu; Bernhard, Jürg et al. (2016) Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial. J Clin Oncol 34:1601-10
Ha, Il Do; Christian, Nicholas J; Jeong, Jong-Hyeon et al. (2016) Analysis of clustered competing risks data using subdistribution hazard models with multivariate frailties. Stat Methods Med Res 25:2488-2505

Showing the most recent 10 out of 211 publications